Jenny Chen focuses her practice on US and foreign patent prosecution and portfolio strategy, opinion work, due diligence, and post-grant matters such as interference, inter partes review, and reexamination. Jenny counsels clients in the areas of biological, medical, and pharmaceutical sciences. She has worked on projects related to biosimilars, diagnosis and treatment for various diseases, vaccine technologies, drug discovery, antibiotic biosynthesis, medical implants, gene- and cell-based therapies, pharmaceutical formulations, and herb extracts.

Prior to joining the firm, Jenny was an associate at Occhiuti Rohlicek & Tsao, LLP in Cambridge, MA, a law clerk and associate at Fish & Richardson, PC., Boston, MA, an intern at a pharmaceutical company, and an intern at Great Boston Legal Service. Jenny was previously a postdoctoral fellow in the laboratory of Dr. David Hafler at Brigham & Women’s Hospital, Harvard Medical School. Her research focused on T cell activity in autoimmune diseases such as Type I diabetes. Jenny received her PhD degree from Baylor College of Medicine, with a focus in molecular biology and pharmacology.

Client testimonial:
"Jenny Chen understands our technology like it is nothing; she picked it up immediately...and she continues to have a very, very good level of service that is beyond any level of expectation."
Client testimonial:
"Jenny has been the contact with the foreign associates, and many times she helps by handling questions with other jurisdictions and has a good rapport with all of our associates in other jurisdictions on the international patents and applications."
Client testimonial:
"Jenny defines what it means to get quality work. It is timely and at a reasonable cost."
  • Assisted leading academic institution in securing patent protection for diagnostic test expected to be used on millions of patients in determining risks for adverse drug reactions.
  • Prosecuted patent applications in areas of diagnostics, therapeutics, and pharmaceuticals in early phases of development.
  • Conducted clearance analysis in connection with clients’ contemplated generic and biosimilar drug marketing.
  • Conducted due diligence studies on patent landscape and market exclusivity in connection with biotech transaction.
  • Successfully demonstrated continuous diligence for an 11-month period in an interference proceeding.
  • American Bar Association
  • American Intellectual Property Law Association
  • Chinese American Intellectual Property Law Association

Jenny has repeatedly been named one of Massachusetts Super Lawyers' "Rising Stars" in the field of intellectual property law.

Articles

December 15, 2016

Opting for PGR over IPR: A Cautionary Tale

January 28, 2015

Looking Behind The Different Invalidation Rates Of Oppositions And IPRs

Blogs

October 13, 2016

Opting for PGR Over IPR: A Cautionary Tale

July 23, 2015

A Kinder, Gentler Face for the Patent Death Squad?



Scientific Publications

Kent SC, Chen Y, Clemmings SM, Viglietta V, Kenyon NS, Ricordi C, Hering B, Hafler DA. (2005) Loss of IL-4 secretion from human type 1a diabetic pancreatic draining lymph node NKT cells. J Immunol. 1;175(7):4458-64.

Kent SC*, Chen Y*, Bregoli L, Clemmings SM, Kenyon NS, Ricordi C, Hering BJ, Hafler DA. (2005) Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope. Nature. 12;435(7039):224-8. *: co-contribution

Chen Y, Perumal K, Reddy R. (2000) Inhibition of translation of mRNAs containing gamma-monomethylphosphate cap structure in frog oocytes and in mammalian cells. Gene Expr. 9(3):133-43.

Chen Y, Sinha K, Perumal K, Reddy R. (2000) Effect of 3' terminal adenylic acid residue on the uridylation of human small RNAs in vitro and in frog oocytes. RNA. 6(9):1277-88.

Sinha K, Perumal K, Chen Y, Reddy R. (1999) Post-transcriptional adenylation of signal recognition particle RNA is carried out by an enzyme different from mRNA Poly(A) polymerase. J Biol Chem. 22;274(43):30826-31.

Chen Y, Sinha K, Perumal K, Gu J, Reddy R. (1998) Accurate 3' end processing and adenylation of human signal recognition particle RNA and alu RNA in vitro. J Biol Chem. 25;273(52):35023-31.

Sinha KM, Gu J, Chen Y, Reddy R. (1998) Adenylation of small RNAs in human cells. Development of a cell-free system for accurate adenylation on the 3'-end of human signal recognition particle RNA. J Biol Chem. 20;273(12):6853-9.

Gu J, Chen Y, Reddy R. (1998) Small RNA database. Nucleic Acids Res. 1;26(1):160-2.


Jenny is the Director of Monte Jade New England.

Expand All

Jenny Chen focuses her practice on US and foreign patent prosecution and portfolio strategy, opinion work, due diligence, and post-grant matters such as interference, inter partes review, and reexamination. Jenny counsels clients in the areas of biological, medical, and pharmaceutical sciences. She has worked on projects related to biosimilars, diagnosis and treatment for various diseases, vaccine technologies, drug discovery, antibiotic biosynthesis, medical implants, gene- and cell-based therapies, pharmaceutical formulations, and herb extracts.

Prior to joining the firm, Jenny was an associate at Occhiuti Rohlicek & Tsao, LLP in Cambridge, MA, a law clerk and associate at Fish & Richardson, PC., Boston, MA, an intern at a pharmaceutical company, and an intern at Great Boston Legal Service. Jenny was previously a postdoctoral fellow in the laboratory of Dr. David Hafler at Brigham & Women’s Hospital, Harvard Medical School. Her research focused on T cell activity in autoimmune diseases such as Type I diabetes. Jenny received her PhD degree from Baylor College of Medicine, with a focus in molecular biology and pharmacology.

Client testimonial:
"Jenny Chen understands our technology like it is nothing; she picked it up immediately...and she continues to have a very, very good level of service that is beyond any level of expectation."
Client testimonial:
"Jenny has been the contact with the foreign associates, and many times she helps by handling questions with other jurisdictions and has a good rapport with all of our associates in other jurisdictions on the international patents and applications."
Client testimonial:
"Jenny defines what it means to get quality work. It is timely and at a reasonable cost."
  • Assisted leading academic institution in securing patent protection for diagnostic test expected to be used on millions of patients in determining risks for adverse drug reactions.
  • Prosecuted patent applications in areas of diagnostics, therapeutics, and pharmaceuticals in early phases of development.
  • Conducted clearance analysis in connection with clients’ contemplated generic and biosimilar drug marketing.
  • Conducted due diligence studies on patent landscape and market exclusivity in connection with biotech transaction.
  • Successfully demonstrated continuous diligence for an 11-month period in an interference proceeding.
  • American Bar Association
  • American Intellectual Property Law Association
  • Chinese American Intellectual Property Law Association

Jenny has repeatedly been named one of Massachusetts Super Lawyers' "Rising Stars" in the field of intellectual property law.

Scientific Publications

Kent SC, Chen Y, Clemmings SM, Viglietta V, Kenyon NS, Ricordi C, Hering B, Hafler DA. (2005) Loss of IL-4 secretion from human type 1a diabetic pancreatic draining lymph node NKT cells. J Immunol. 1;175(7):4458-64.

Kent SC*, Chen Y*, Bregoli L, Clemmings SM, Kenyon NS, Ricordi C, Hering BJ, Hafler DA. (2005) Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope. Nature. 12;435(7039):224-8. *: co-contribution

Chen Y, Perumal K, Reddy R. (2000) Inhibition of translation of mRNAs containing gamma-monomethylphosphate cap structure in frog oocytes and in mammalian cells. Gene Expr. 9(3):133-43.

Chen Y, Sinha K, Perumal K, Reddy R. (2000) Effect of 3' terminal adenylic acid residue on the uridylation of human small RNAs in vitro and in frog oocytes. RNA. 6(9):1277-88.

Sinha K, Perumal K, Chen Y, Reddy R. (1999) Post-transcriptional adenylation of signal recognition particle RNA is carried out by an enzyme different from mRNA Poly(A) polymerase. J Biol Chem. 22;274(43):30826-31.

Chen Y, Sinha K, Perumal K, Gu J, Reddy R. (1998) Accurate 3' end processing and adenylation of human signal recognition particle RNA and alu RNA in vitro. J Biol Chem. 25;273(52):35023-31.

Sinha KM, Gu J, Chen Y, Reddy R. (1998) Adenylation of small RNAs in human cells. Development of a cell-free system for accurate adenylation on the 3'-end of human signal recognition particle RNA. J Biol Chem. 20;273(12):6853-9.

Gu J, Chen Y, Reddy R. (1998) Small RNA database. Nucleic Acids Res. 1;26(1):160-2.

Articles

December 15, 2016

Opting for PGR over IPR: A Cautionary Tale

January 28, 2015

Looking Behind The Different Invalidation Rates Of Oppositions And IPRs

Blogs

October 13, 2016

Opting for PGR Over IPR: A Cautionary Tale

July 23, 2015

A Kinder, Gentler Face for the Patent Death Squad?


Jenny is the Director of Monte Jade New England.